A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression-Reference-Cited by-同舟云学术

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression

Published:2021-06-09 Issue:597 Volume:13 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Nagele Peter¹^ORCID,Palanca Ben J.²^ORCID,Gott Britt³,Brown Frank¹,Barnes Linda³,Nguyen Thomas²^ORCID,Xiong Willa³^ORCID,Salloum Naji C.³,Espejo Gemma D.³^ORCID,Lessov-Schlaggar Christina N.³^ORCID,Jain Nisha¹^ORCID,Cheng Wayland W. L.²^ORCID,Komen Helga²^ORCID,Yee Branden²^ORCID,Bolzenius Jacob D.²^ORCID,Janski Alvin³^ORCID,Gibbons Robert⁴^ORCID,Zorumski Charles F.³⁵^ORCID,Conway Charles R.³⁵^ORCID

Affiliation:

1. Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL 60637, USA.

2. Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.

3. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.

4. Center for Health Statistics, University of Chicago, Chicago, IL 60637, USA.

5. Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO 63110, USA.

Abstract

Twenty-five percent inhaled nitrous oxide improves symptoms of treatment-resistant major depression with fewer adverse effects than the 50% concentration.

Funder

Brain and Behavior Research Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference25 articles.

1. Prognosis and improved outcomes in major depression: a review

2. Prospective, Long-Term, Multicenter Study of the Naturalistic Outcomes of Patients With Treatment-Resistant Depression

3. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report

4. Prevalence of treatment-resistant depression in primary care: cross-sectional data

5. Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Anesthetic Agents in Depression;Cottrell & Patel's Neuroanesthesia;2025

2. Self-adjusted Nitrous Oxide During Urodynamic Studies Reduces Patient Pain Without Compromising Study Quality: A Randomized Controlled Trial;European Urology Open Science;2024-10

3. Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression;European Archives of Psychiatry and Clinical Neuroscience;2024-08-29

4. Nitrous Oxide Alters Functional Connectivity in Medial Limbic Structures in Treatment-Resistant Major Depression;2024-08-17

5. Management of Depression and Anxiety in Perioperative Medicine;Anesthesiology;2024-08-13